N Engl J Med 2024 Jul 25
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults.
Related Questions
Does your approach change if the MRD is negative post-blinatumomab?
New answer by Medical Oncologist at University of Washington (October 2, 2025)
To my knowledge, there have not been any prospective trials in the modern era that specifically address the issue of the duration of maintenance therapy in adults with ALL.Mos...